• Shuai Shi, Xinyu Ji, Yanping Wang, Bin Liu, Huamin Zhang, and Cheng Lu.
• Guang'anmen Hospital.
• Medicine (Baltimore). 2019 Oct 1; 98 (42): e17563e17563.

BackgroundThe objective of this systematic review protocol is to provide the methods for evaluating the effectiveness and safety of acupuncture on the treatment of myasthenia gravis (MG).Methods And AnalysisWe will search randomized controlled trials (RCTs) on this subject in 8 electronic databases and they are Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, PubMed, Chinese Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), the Wan-Fang Database, and Chinese Scientific Journal Database (VIP database). Other relevant literatures will be manually searched as a complement. Only RCTs related to acupuncture for MG will be included, without Language restrictions and limitation of publication types. The risk of bias and trial quality will be assessed by the Cochrane collaboration tool. The study inclusion, data extraction and quality assessment will be conducted independently by 2 reviewers. All data from the studies included will be analyzed by RevMan V.5.3 statistical software.ResultsThis study will provide a high-quality synthesis of RCTs on the efficacy and safety of acupuncture as an adjuvant therapy in the treatment of MG.ConclusionThis systemic review will provide high quality evidence to evaluate acupuncture as adjuvant therapy in patients with MG.Prospero Registration NumberPROSPERO CRD42019133577.

9 keywords...

hide…